GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: This is a heterobifunctional cereblon-binding PROTAC degrader that is selective for phosphoinositide 3-kinase (PI3K) isoforms α and δ [1]. It exploits copanlisib as the PI3K-targeting warhead. D5 is proposed for therapeutic potential in PIK3CA mutant breast cancers (with the oncogenic H1047R mutation for example).
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Ho Y, Zheng X, Zhang Y, Shen H, Kang C, Qin H, Cao S, Zhu Y, Wang X, Sun C et al.. (2026)
Rational Design of Potent and Orally Efficacious PI3Kα/δ Degrader for PIK3CA Mutant Breast Cancer without Hyperglycemic Liability. J Med Chem, Epub ahead of print. DOI: 10.1021/acs.jmedchem.5c03368 |